第四章 度他雄胺软胶囊fda说明书.pdfVIP

  • 7
  • 0
  • 约7.78万字
  • 约 24页
  • 2017-10-05 发布于湖北
  • 举报
HIGHLIGHTS OF PRESCRIBING INFORMATION Patients with previously demonstrated, clinically significant These highlights do not include all the information needed to use hypersensitivity (e.g., serious skin reactions, angioedema) to AVODART safely and effectively. See full prescribing information for AVODART or other 5 alpha-reductase inhibitors. (4) AVODART.

文档评论(0)

1亿VIP精品文档

相关文档